Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Functional PET imaging of gut microbiota with [<sup>18</sup>F]fluorodeoxyglucose, [<sup>18</sup>F]fluorodeoxysorbitol and [<sup>11</sup>C]choline reflects Clostridia and Lactobacillales abundance in caecum and small intestine and host metabolic interactions.

European journal of nuclear medicine and molecular imaging·2026

Same author

Plantar fascia thickness in type 1 diabetes mellitus patients: Clinical associations and metabolic correlates.

Journal of diabetes investigation·2026

Same author

Residual coronary atherosclerotic risk and low LDL-cholesterol in chronic coronary syndromes.

European heart journal. Imaging methods and practice·2026

Same author

Non-Coding RNA Profile in the Progression of Carotid Atherosclerosis: A Systematic Review.

International journal of molecular sciences·2026

Same author

Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy.

The Cochrane database of systematic reviews·2026

Same author

Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated Steatohepatitis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

A psychological support program for individuals with Type 1 diabetes.

Gabriele Forlani¹, Chiara Nuccitelli, Chiara Caselli

¹Unit of Metabolic Diseases and Clinical Dietetics, "Alma Mater Studiorum" University, S. Orsola-Malpighi Hospital, Via Massarenti, 9, I-40138, Bologna, Italy.

Acta Diabetologica

|March 3, 2011

Summary

A psychological support program significantly improved mood and quality of life for individuals with type 1 diabetes. The intervention reduced depressive mood and anxiety, enhancing overall well-being and disease management.

Related Experiment Videos

Last Updated: Jun 4, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Area of Science:

Psychology
Endocrinology
Public Health

Background:

Type 1 diabetes requires comprehensive management beyond glycemic control.
Psychological distress is common in individuals with chronic conditions like type 1 diabetes.
Well-educated individuals with type 1 diabetes may benefit from targeted psychological support.

Purpose of the Study:

To evaluate the impact of a novel psychological support program on psychological distress, mood, and quality of life in well-educated individuals with type 1 diabetes.
To assess changes in locus of control and glycosylated hemoglobin (HbA1c) levels following the intervention.

Main Methods:

A randomized controlled trial involving 60 patients with type 1 diabetes on intensive insulin therapy.
The experimental group (33 participants) received 7 weekly 2-hour sessions led by a psychologist, utilizing role-playing, metaphor, and problem-solving techniques.
The control group (22 participants) postponed entry. Assessments included validated questionnaires (Beck Depression Inventory, Self-rating Anxiety Scale, Well-Being Enquiry for Diabetes) at baseline and 6 months, analyzed using repeated-measures ANOVA.

Main Results:

The experimental group showed significant reductions in depressive mood and anxiety.
Participants reported improvements in disease-specific quality of life and a shift towards an internal locus of control.
A statistically significant decrease of 0.3% in glycosylated hemoglobin (HbA1c) was observed in the intervention group (P = 0.032).
No significant changes were noted in the control group.

Conclusions:

Psychological support programs can effectively mitigate psychological distress and enhance quality of life in individuals with type 1 diabetes.
Addressing psychological aspects is crucial for comprehensive diabetes management, potentially complementing medical control.
The findings highlight the interconnectedness of mental health and physical outcomes in type 1 diabetes management.